Anacortes Mining Ret. on equity
What is the Ret. on equity of Anacortes Mining?
The Ret. on equity of Anacortes Mining Corporation is -242.68%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Finance sector on TSXV compared to Anacortes Mining
What does Anacortes Mining do?
Anacortes Mining Corp. explores for and develops gold properties in Peru and Canada. It holds a 100% interest in the Tres Cruces gold project in north central Peru; and a 100% interest in one mineral property located in Ontario, Canada. The company was incorporated in 1994 and is headquartered in Vancouver, Canada.
Companies with ret. on equity similar to Anacortes Mining
- Sky and Space Global has Ret. on equity of -245.37%
- Braille Systems has Ret. on equity of -245.19%
- Eskay Mining has Ret. on equity of -245.17%
- IQ-AI has Ret. on equity of -244.23%
- Goldeneye Resources has Ret. on equity of -243.63%
- Delcath Systems has Ret. on equity of -243.35%
- Anacortes Mining has Ret. on equity of -242.68%
- Taysha Gene Therapies has Ret. on equity of -242.57%
- Evershine has Ret. on equity of -242.21%
- Taiga Motors has Ret. on equity of -242.13%
- TAAT Lifestyle & Wellness has Ret. on equity of -242.05%
- AdAlta has Ret. on equity of -241.80%
- Cara Therapeutics Inc has Ret. on equity of -241.31%